Skip to main content
. Author manuscript; available in PMC: 2018 Jun 1.
Published in final edited form as: Mol Genet Metab. 2017 Apr 19;121(2):119–126. doi: 10.1016/j.ymgme.2017.04.007

Table 1B.

Hospitalization characteristics, outcomes, costs, and charges, summary.

Hospitalizations in 2012, HCUP-KID
Pediatric (under 21 years), with Mitochondrial Disease Pediatric (under 21 years), without Mitochondrial Disease
Emergency room (ER) use Percentage in category (n) Percentage in category
 % with ER use 54.9 (1772) 45.3 (1,329,463)
Number of in-hospital diagnoses, by age group(years) Median (IQI) Median (IQI)
 <2 9.4 (6.3, 14.1) 2.8 (1.5, 5.0)
 2 – <18 9.0 (6.0, 13.3) 3.1 (1.6, 5.3)
 18 – <21 9.8 (6.5, 13.5) 3.9 (2.2, 6.1)
Principal admitting diagnosis, 5 most common Diagnosis % of total (n) Diagnosis % of total (n)
Other nutritional,endocrine, metabolic1 12.5 (403.2) Mood disorders 5.5 (160,664)
Epilepsy 11.6 (374.0) Pneumonia 4.5 (130,796)
Complication of device; implant or graft 6.7 (215.1) Asthma 4.4 (128,011)
Pneumonia 5.2 (166.5) Bronchitis 4.2 (124,068)
Fluid/electrolyte disorders 4.5 (145.3) Delivery-related 3.2 (93,927)
Major operating room procedure? Percentage (n) Percentage (n)
 Yes 13.4 (434) 20.7 (607,259)
Length of stay Median (IQI) Median (IQI)
3.1 (1.4, 7.1) 1.9 (1.0, 3.6)
In-hospital death? Percentage (n) Percentage (n)
 Yes 2.4 (77) 0.4 (11,943)
Hospital costs Median (IQI) Median (IQI)
$9,037 ($4,346, $20,728) $4,240 ($2,474, $8,206)

IQI = inter-quartile interval.

1

Includes the diagnosis of mitochondrial disease itself.

Values in bold text are statistically significantly different between individuals with and without mitochondrial disease.